Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05102188 · ClinicalTrials.gov registry record
Addressing Health Disparities in African Americans - Exploring Sleep and Developing Interventions - 2
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 80
- Enrollment target
NCT05102188: Completed study, sponsored by Pennington Biomedical Research Center.
NCT05102188 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05102188 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The purpose of the HD-SLEEP2 study is to help researchers understand sleep in African Americans. The investigators also want to know what factors may affect sleep.
Primary Outcome
Average hours of sleep/24h period
Interventions
- COMBINATION_PRODUCT Assessment of sleep and related factors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-03-11 |
| Est. Completion | 2022-12-31 |
What the finished NCT05102188 record still lists
NCT05102188 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Assessment of sleep and related factors is the first listed.
NCT05102188 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05102188 about?
NCT05102188 is a clinical study titled "Addressing Health Disparities in African Americans - Exploring Sleep and Developing Interventions - 2". The purpose of the HD-SLEEP2 study is to help researchers understand sleep in African Americans. The investigators also want to know what factors may affect sleep.
What is the current status of trial NCT05102188?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2022-03-11. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT05102188?
The interventions under investigation include: Assessment of sleep and related factors (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05102188?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI